54 related articles for article (PubMed ID: 35505059)
1. Differential Dopamine D1 and D3 Receptor Modulation and Expression in the Spinal Cord of Two Mouse Models of Restless Legs Syndrome.
Meneely S; Dinkins ML; Kassai M; Lyu S; Liu Y; Lin CT; Brewer K; Li Y; Clemens S
Front Behav Neurosci; 2018; 12():199. PubMed ID: 30233336
[TBL] [Abstract][Full Text] [Related]
2. Presynaptic and postsynaptic mesolimbic dopamine D
Xi ZX; Bocarsly ME; Galaj E; Hempel B; Teresi C; Shaw M; Bi GH; Jordan C; Linz E; Alton H; Tanda G; Freyberg Z; Alvarez VA; Newman AH
Biol Psychiatry; 2024 Jun; ():. PubMed ID: 38838841
[TBL] [Abstract][Full Text] [Related]
3. 17-β-estradiol potentiates the neurotrophic and neuroprotective effects mediated by the dopamine D3/acetylcholine nicotinic receptor heteromer in dopaminergic neurons.
Sbrini G; Mutti V; Bono F; Tomasoni Z; Fadel D; Missale C; Fiorentini C
Eur J Pharmacol; 2024 Aug; 976():176678. PubMed ID: 38821163
[TBL] [Abstract][Full Text] [Related]
4. Current Perspectives on Selective Dopamine D
Newman AH; Xi ZX; Heidbreder C
Curr Top Behav Neurosci; 2023; 60():157-201. PubMed ID: 35543868
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a Stereoselective Mechanism for Bitopic Activity by Extended-Length Antagonists of the D
Moritz AE; Bonifazi A; Guerrero AM; Kumar V; Free RB; Lane JR; Verma RK; Shi L; Newman AH; Sibley DR
ACS Chem Neurosci; 2020 Oct; 11(20):3309-3320. PubMed ID: 32969645
[TBL] [Abstract][Full Text] [Related]
6. Modulation of D
Casados-Delgado O; Avalos-Fuentes JA; Lara-Lozano M; Tovar-Medina G; Florán-Hernández CD; Martínez-Nolasco KG; Cortes H; Felix R; Segovia J; Florán B
Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255311
[TBL] [Abstract][Full Text] [Related]
7. Arrestin-3 Agonism at Dopamine D
Schamiloglu S; Lewis E; Keeshen CM; Hergarden AC; Bender KJ; Whistler JL
Biol Psychiatry; 2023 Oct; 94(7):531-542. PubMed ID: 36931452
[TBL] [Abstract][Full Text] [Related]
8. Type 2β Corticotrophin Releasing Factor Receptor Forms a Heteromeric Complex With Dopamine D1 Receptor in Living Cells.
Yarur HE; Andrés ME; Gysling K
Front Pharmacol; 2019; 10():1501. PubMed ID: 31969820
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Human Dopamine D3 Receptor Quaternary Structure.
Marsango S; Caltabiano G; Pou C; Varela Liste MJ; Milligan G
J Biol Chem; 2015 Jun; 290(24):15146-62. PubMed ID: 25931118
[TBL] [Abstract][Full Text] [Related]
10. The dopamine 3 receptor as a candidate biomarker and therapeutic for opioid use disorder.
Banks ML; Sprague JE
Addict Biol; 2024 Feb; 29(2):e13369. PubMed ID: 38380709
[TBL] [Abstract][Full Text] [Related]
11. Substance Addiction Rehabilitation Drugs.
Yuan S; Jiang SC; Zhang ZW; Li ZL; Hu J
Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794185
[TBL] [Abstract][Full Text] [Related]
12. Targeting dopamine receptor D3 signalling in inflammation.
Pacheco R
Oncotarget; 2017 Jan; 8(5):7224-7225. PubMed ID: 28086229
[No Abstract] [Full Text] [Related]
13. Recent Advances in Dopamine D3 Receptor Heterodimers: Focus on Dopamine D3 and D1 Receptor-Receptor Interaction and Striatal Function.
Bono F; Mutti V; Tomasoni Z; Sbrini G; Missale C; Fiorentini C
Curr Top Behav Neurosci; 2023; 60():47-72. PubMed ID: 35505059
[TBL] [Abstract][Full Text] [Related]
14. G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2.
Bono F; Tomasoni Z; Mutti V; Sbrini G; Kumar R; Longhena F; Fiorentini C; Missale C
Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979407
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D3 Receptor Modulates l-DOPA-Induced Dyskinesia by Targeting D1 Receptor-Mediated Striatal Signaling.
Solís O; Garcia-Montes JR; González-Granillo A; Xu M; Moratalla R
Cereb Cortex; 2017 Jan; 27(1):435-446. PubMed ID: 26483399
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological targeting of G protein-coupled receptor heteromers.
Moreno E; Casajuana-Martin N; Coyle M; Campos BC; Galaj E; Del Torrent CL; Seyedian A; Rea W; Cai NS; Bonifazi A; Florán B; Xi ZX; Guitart X; Casadó V; Newman AH; Bishop C; Pardo L; Ferré S
Pharmacol Res; 2022 Nov; 185():106476. PubMed ID: 36182040
[TBL] [Abstract][Full Text] [Related]
17. The D3 dopamine receptor: From structural interactions to function.
Fiorentini C; Savoia P; Bono F; Tallarico P; Missale C
Eur Neuropsychopharmacol; 2015 Sep; 25(9):1462-9. PubMed ID: 25532864
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
